1887

n Southern African Journal of HIV Medicine - Influenza immunisation in HIV-infected persons : fighting flu

USD

 

Abstract

Influenza vaccines are widely used throughout the world. Some 80 - 85 million doses are produced annually for distribution in the USA alone where coverage for the major risk group, persons over 65 years of age, was 63% in 1997 (surpassing the 6O% vaccine coverage goal for the country's Healthy People 2000 Project). The clinical effectiveness as well as the cost effectiveness of influenza vaccines have been clearly established in a number of studies in many parts of the world. Influenza vaccination has also been demonstrated to reduce hospitalisation significantly in elderly high-risk persons. In South Africa, influenza immunisation has similarly been demonstrated to be cost effective and utilisation of vaccine in this country has increased markedly over the past few years, reaching over 2 million doses administered in 2000. Annual influenza immunisation is sound preventive medicine generally, and in particular is mandated for persons at risk for complications of influenza.

Loading

Article metrics loading...

/content/m_sajhiv/2/1/EJC65638
2001-01-01
2016-12-06
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error